Table 2: Spectrum of suspected adverse drug reactions of nanoparticle versus conventional paclitaxel formulation
|
|
Close |
|
Table 2: Spectrum of suspected adverse drug reactions of nanoparticle versus conventional paclitaxel formulation
|
|